Information Provided By:
Fly News Breaks for January 12, 2017
BX, BKD
Jan 12, 2017 | 06:30 EDT
Wells Fargo analyst Ryan Halsted upgraded Brookdale Senior Living (BKD) to Outperform citing a higher probability that the company will sell some or all of its assets. The analyst raised his price target range for the shares to $18-$21 from $14-$16. A sale of the whole company to Blackstone (BX) is a possibility, Halsted tells investors in a research note.
News For BKD;BX From the Last 2 Days
BX
Mar 27, 2024 | 06:37 EDT
Blackstone (BX) announced a new collaboration with Moderna (MRNA) through a development and commercialization funding agreement where funds managed by Blackstone Life Sciences will provide up to $750M to fund Moderna's influenza program. This new collaboration continues Blackstone Life Sciences' work and support for many of the world's leading and most innovative biopharmaceutical and medical technology companies. Blackstone seeks to provide customized financing solutions for companies across therapeutic areas to support mission critical scientific innovation and advance important products to patients.